Literature DB >> 15816327

The control of cardiomyocyte apoptosis via the beta-adrenergic signaling pathways.

C Communal1, W S Colucci.   

Abstract

Cardiomyocyte death resulting from apoptosis has been implicated in the evolution of heart failure. In this review, we focus on the concept that the cardiotoxicity of excessive sympathetic nervous system activity observed in heart failure is in part due to myocytes death by apoptosis. In vitro, high doses of norepinephrine induce adult cardiomyocyte apoptosis via 3-adrenergic receptor-coupled signaling pathways (PKA and Ca2+ entry-dependent mechanisms). beta1-and beta2-AR co-exist in the cardiac cell. beta1-AR stimulation is pro-apoptotic, whereas beta2-AR stimulation is anti-apoptotic, mediating its protective effect via coupling to Gi. These in vitro observations have been confirmed in transgenic mice: cardiac beta1-AR overexpression increases apoptosis and leads to heart failure, whereas cardiac beta2-AR overexpression has no deleterious effects. beta-AR stimulation activates p38 kinases and JNK (via the small GTP protein Rac1); and exert anti- and pro-apoptotic effects, respectively. Other studies suggest that beta1-AR-stimulated apoptosis is dependent on Ca2+ -activated calmodulin kinase II and that the anti-apoptotic effect of beta2-AR is mediated via Akt-coupled pathways. beta-AR-stimulated apoptosis involves the mitochondrial pathway. Inhibition of mitochondrial permeability transition pore opening or caspase activation decreases beta-AR-stimulated apoptosis. Reactive oxygen species production is also involved in this process since superoxide dismutase/catalase-mimetics or catalase overexpression prevent beta-AR-stimulated apoptosis. In vivo, it has been shown that beta-AR blockers such as metoprolol and carvedilol have beneficial effects in animal models of chronic heart failure, associated with reduced apoptosis and improved cardiac systolic function. Understanding the mechanisms involved in the control of myocyte loss by the beta-adrenergic system will have direct clinical implications by improving the treatment of heart failure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15816327

Source DB:  PubMed          Journal:  Arch Mal Coeur Vaiss        ISSN: 0003-9683


  19 in total

Review 1.  Calcium cycling proteins and their association with heart failure.

Authors:  L Hadri; R J Hajjar
Journal:  Clin Pharmacol Ther       Date:  2011-08-10       Impact factor: 6.875

Review 2.  Contribution of apoptosis in myocardial reperfusion injury and loss of cardioprotection in diabetes mellitus.

Authors:  Reza Badalzadeh; Behnaz Mokhtari; Raana Yavari
Journal:  J Physiol Sci       Date:  2015-03-01       Impact factor: 2.781

Review 3.  Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver.

Authors:  Hassan K Awada; Mintai P Hwang; Yadong Wang
Journal:  Biomaterials       Date:  2015-12-29       Impact factor: 12.479

4.  Mechanisms of the beneficial effects of beta-adrenoceptor antagonists in congestive heart failure.

Authors:  Navneet S Rehsia; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2010

5.  Differential roles of Epac in regulating cell death in neuronal and myocardial cells.

Authors:  Sayaka Suzuki; Utako Yokoyama; Takaya Abe; Hiroshi Kiyonari; Naoya Yamashita; Yuko Kato; Reiko Kurotani; Motohiko Sato; Satoshi Okumura; Yoshihiro Ishikawa
Journal:  J Biol Chem       Date:  2010-06-01       Impact factor: 5.157

Review 6.  Mechanisms of disease: detrimental adrenergic signaling in acute decompensated heart failure.

Authors:  David S Feldman; Terry S Elton; Benjamin Sun; Mickey M Martin; Mark T Ziolo
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-02-19

7.  Cardiotoxic and cardioprotective features of chronic β-adrenergic signaling.

Authors:  Xiaoying Zhang; Christopher Szeto; Erhe Gao; Mingxin Tang; Jianguo Jin; Qin Fu; Catherine Makarewich; Xiaojie Ai; Ying Li; Allen Tang; Jenny Wang; Hui Gao; Fang Wang; Xinyi Joy Ge; Satya P Kunapuli; Lin Zhou; Chunyu Zeng; Kevin Yang Xiang; Xiongwen Chen
Journal:  Circ Res       Date:  2012-10-25       Impact factor: 17.367

8.  Prevalent role of Akt and ERK activation in cardioprotective effect of Ca(2+) channel- and beta-adrenergic receptor blockers.

Authors:  Krisztina Kovacs; Katalin Hanto; Zita Bognar; Antal Tapodi; Eszter Bognar; Gyongyi N Kiss; Aliz Szabo; Gabor Rappai; Tamas Kiss; Balazs Sumegi; Ferenc Gallyas
Journal:  Mol Cell Biochem       Date:  2008-10-31       Impact factor: 3.396

9.  {beta}1-Adrenergic receptor activation induces mouse cardiac myocyte death through both L-type calcium channel-dependent and -independent pathways.

Authors:  Wei Wang; Hongyu Zhang; Hui Gao; Hajime Kubo; Remus M Berretta; Xiongwen Chen; Steven R Houser
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-05-21       Impact factor: 4.733

Review 10.  Myocardial protection in man--from research concept to clinical practice.

Authors:  Dennis V Cokkinos; Costas Pantos
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.